Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

18.5%

20 terminated/withdrawn out of 108 trials

Success Rate

69.2%

-17.3% vs industry average

Late-Stage Pipeline

8%

9 trials in Phase 3/4

Results Transparency

24%

11 of 45 completed trials have results

Key Signals

11 recruiting11 with results18 terminated

Enrollment Performance

Analytics

N/A
53(60.9%)
Phase 2
17(19.5%)
Phase 3
9(10.3%)
Phase 1
6(6.9%)
Early Phase 1
2(2.3%)
87Total
N/A(53)
Phase 2(17)
Phase 3(9)
Phase 1(6)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (108)

Showing 20 of 108 trials
NCT07575750Not ApplicableNot Yet Recruiting

Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Aromatase Inhibitor-induced Arthralgia (AIA): a Phase 2, Randomized, Monocentric, taVNS Versus Sham, Double Blind

Role: lead

NCT03794388Phase 3Completed

Evaluation in the Treatment of Neuropathic Pain Post Breast Surgery

Role: lead

NCT02143219Phase 2Completed

Efficacy and Tolerance Evaluation in FOLFIRINOX Dose Adjusted in Elderly Patients With a Metastatic Pancreatic Cancer

Role: lead

NCT05189366Not ApplicableTerminated

Sophrology Treatment for Patients With Glial Tumours Requiring Speech Therapy

Role: lead

NCT05840562Phase 3Recruiting

Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy

Role: lead

NCT03795207Phase 2Active Not Recruiting

Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736)

Role: lead

NCT04890028Not ApplicableCompleted

Detection and Metabolic Characterization in DOPA PET/CT of Brain Metastases

Role: lead

NCT02890082Phase 2Active Not Recruiting

Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer

Role: lead

NCT05981326Not ApplicableRecruiting

Prediction in Silico of Pathological Response in a Prospective Cohort Study of Early Breast Cancer Patients

Role: lead

NCT07468838Not Yet Recruiting

Feasibility Study of Urinary cfDNA Analysis as a Non-invasive Monitoring Tool in Patients With Prostate or Bladder Cancer

Role: lead

NCT05316389Active Not Recruiting

Retrospective and Prospective Evaluation of Scapulohumeral Comfort, Aesthetic Result and Quality of Life

Role: lead

NCT06994702Not ApplicableCompleted

Impact of the MRI Restraint System on the Quality of the Synthetic Scan for Intracranial Radiotherapy Treatment

Role: lead

NCT04343820Completed

Delayed Breast Reconstruction by Prepectoral Implant After Lipo-preparation (RM2prepec)

Role: lead

NCT06051214Not ApplicableRecruiting

Thrombin Generation and Prediction of Thromboembolic Events in Oncology Patients at Risk

Role: lead

NCT06756802Active Not Recruiting

Reproductive Health in Breast Cancer Survivor

Role: lead

NCT02274779Phase 2Completed

Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer

Role: lead

NCT04625621Completed

Breast Reconstruction by Exclusive Lipomodulin : Feasibility, Evaluation of the Aesthetic Result and Quality of Life

Role: lead

NCT05343975Completed

Evaluating the Value of Audio-guided Meditation During Breast Biopsy Procedures

Role: lead

NCT05527769Completed

Pain and Functional Recovery After Mastectomy and IBR by Implant: Prepectoral Versus Subpectoral Technique

Role: lead

NCT04916054Completed

Time to Surgery and Survival Outcomes for Patients With Resected Colorectal Carcinoma: Multicenter Study (BIG RENAPE)

Role: lead